Finally, the results of Western blotting showed that the potential anti-cancer mechanism of the traditional Naxi formula CLYF may be related to inhibiting the relative protein expression of EGFR and AKT1 while promoting the relative protein expression of TP53. The gene discussed is EGFR; the disease is cancer.